Statistics from Altmetric.com
Background: Bone metastases are very common in cancer, with an incidence of over 75% in breast and prostate. It is important to be able to determine quantitatively the impact of bone metastases on patients’ lives. The international development of a bone metastases module for the European Organisation for Research and Treatment of Cancer (EORTC) health-related quality of life (HRQoL) modular system 1 is described. Aims: To develop and validate a QoL module for …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.